Skip to main content
SpringerLink
Log in

Thermal Ablation

  • Chapter
  • First Online:
Renal Cell Carcinoma

Part of the book series: Current Clinical Urology ((CCU))

  • 1865 Accesses

Abstract

Thermal ablative therapy with RFA and cryoablation has gained a foothold in the armamentarium of treatments of the small renal mass. Ablative therapies appear to be best suited for patients with difficult medical, anesthetic, or anatomic situations in whom the lower efficacy rates are balanced by the reduced risk of serious adverse events. Elderly patients with an enlarging mass, those with extensive comorbidities, or those with a recurrence after prior partial nephrectomy, these represent situations where thermal ablation may have its best role. While newer energy modalities and delivery devices continue to be investigated, RFA and cryoablation continue to have the largest clinical experience and available data.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Campbell SC, Novick AC, Belldegrun A, et al. Guideline for management of the clinical T1 renal mass. J Urol. 2009;182(4):1271–9.

    Article  PubMed  Google Scholar 

  2. American Urological Association. Guideline for management of the clinical stage 1 renal mass; 2009. Available at http://wwwauanet.org. Accessed 11 Feb 2011.

  3. Hsu TH, Fidler ME, Gill IS. Radiofrequency ablation of the kidney: acute and chronic histology in porcine model. Urology. 2000;56(5):872–5.

    Article  PubMed  CAS  Google Scholar 

  4. Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol. 2000;174(2):323–31.

    CAS  Google Scholar 

  5. Hoffmann NE, Bischof JC. The cryobiology of cryosurgical injury. Urology. 2002;60(2 Suppl 1):40–9.

    Article  PubMed  Google Scholar 

  6. Daum PS, Bowers Jr WD, Tejada J, Hamlet MP. Vascular casts demonstrate microcirculatory insufficiency in acute frostbite. Cryobiology. 1987;24(1):65–73.

    Article  PubMed  CAS  Google Scholar 

  7. Hoffmann NE, Bischof JC. Cryosurgery of normal and tumor tissue in the dorsal skin flap chamber: Part II – injury response. J Biomech Eng. 2001;123(4):310–6.

    Article  PubMed  CAS  Google Scholar 

  8. Finelli A, Rewcastle JC, Jewett MA. Cryotherapy and radiofrequency ablation: pathophysiologic basis and laboratory studies. Curr Opin Urol. 2003;13(3):187–91.

    Article  PubMed  Google Scholar 

  9. Tuncali K, van Sonnenberg E, Shankar S, Mortele KJ, Cibas ES, Silverman SG. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis. Am J Roentgenol. 2004;183(3):575–82.

    Google Scholar 

  10. Lebret T, Poulain JE, Molinie V, et al. Percutaneous core biopsy for renal masses: indications, accuracy and results. J Urol. 2007;178(4 Pt 1):1184–8 [discussion 8].

    Article  PubMed  Google Scholar 

  11. Liu J, Fanning CV. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies. Cancer. 2001;93(6):390–7.

    Article  PubMed  CAS  Google Scholar 

  12. Volpe A, Kachura JR, Geddie WR, et al. Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy. J Urol. 2007;178(2):379–86.

    Article  PubMed  Google Scholar 

  13. Kummerlin I, ten Kate F, Smedts F, et al. Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol. 2008;53(6):1219–25.

    Article  PubMed  Google Scholar 

  14. Matin SF. Determining failure after renal ablative therapy for renal cell carcinoma: false-negative and false-positive imaging findings. Urology. 2010;75(6):1254–7.

    Article  PubMed  Google Scholar 

  15. Weight CJ, Kaouk JH, Hegarty NJ, et al. Correlation of radiographic imaging and histopathology following cryoablation and radio frequency ablation for renal tumors. J Urol. 2008;179(4):1277–81 [discussion 81–3].

    Article  PubMed  Google Scholar 

  16. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. Am J Roentgenol. 2005;185(1):64–71.

    Google Scholar 

  17. Tsivian M, Lyne JC, Mayes JM, Mouraviev V, Kimura M, Polascik TJ. Tumor size and endophytic growth pattern affect recurrence rates after laparoscopic renal cryoablation. Urology. 2010;75(2):307–10.

    Article  PubMed  Google Scholar 

  18. Zagoria RJ, Traver MA, Werle DM, Perini M, Hayasaka S, Clark PE. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas. Am J Roentgenol. 2007;189(2):429–36.

    Article  Google Scholar 

  19. Yoost TR, Clarke HS, Savage SJ. Laparoscopic cryoablation of renal masses: which lesions fail? Urology. 2010;75(2):311–4.

    Article  PubMed  Google Scholar 

  20. Yamakado K, Nakatsuka A, Kobayashi S, et al. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience. Cardiovasc Intervent Radiol. 2006;29(3):389–94.

    Article  PubMed  Google Scholar 

  21. Gupta A, Allaf ME, Kavoussi LR, et al. Computerized tomography guided percutaneous renal cryoablation with the patient under conscious sedation: initial clinical experience. J Urol. 2006;175(2):447–52 [discussion 52–3].

    Article  PubMed  Google Scholar 

  22. Ahrar K, Matin S, Wood CG, et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Interv Radiol. 2005;16(5):679–88.

    Article  PubMed  Google Scholar 

  23. Jacobsohn KM, Ahrar K, Wood CG, Matin SF. Is radiofrequency ablation safe for solitary kidneys? Urology. 2007;69(5):819–23 [discussion 23].

    Article  PubMed  Google Scholar 

  24. Farrell MA, Charboneau JW, Callstrom MR, Reading CC, Engen DE, Blute ML. Paranephric water instillation: a technique to prevent bowel injury during percutaneous renal radiofrequency ablation. Am J Roentgenol. 2003;181(5):1315–7.

    CAS  Google Scholar 

  25. Cantwell CP, Wah TM, Gervais DA, et al. Protecting the ureter during radiofrequency ablation of renal cell cancer: a pilot study of retrograde pyeloperfusion with cooled dextrose 5% in water. J Vasc Interv Radiol. 2008;19(7):1034–40.

    Article  PubMed  Google Scholar 

  26. Gervais DA, Arellano RS, McGovern FJ, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 2, lessons learned with ablation of 100 tumors. Am J Roentgenol. 2005;185(1):72–80.

    Google Scholar 

  27. Javadi S, Ahrar JU, Ninan E, Gupta S, Matin SF, Ahrar K. Characterization of contrast enhancement in the ablation zone immediately after radiofrequency ablation of renal tumors. J Vasc Interv Radiol. 2010;21(5):690–5.

    Article  PubMed  Google Scholar 

  28. Delworth MG, Pisters LL, Fornage BD, von Eschenbach AC. Cryotherapy for renal cell carcinoma and angiomyolipoma. J Urol. 1996;155(1):252–4.

    Article  PubMed  CAS  Google Scholar 

  29. Permpongkosol S, Nielsen ME, Solomon SB. Percutaneous renal cryoablation. Urology. 2006;68(1 Suppl):19–25.

    Article  PubMed  Google Scholar 

  30. Malcolm JB, Berry TT, Williams MB, et al. Single center experience with percutaneous and laparoscopic cryoablation of small renal masses. J Endourol. 2009;23(6):907–11.

    Article  PubMed  Google Scholar 

  31. Schmit GD, Atwell TD, Callstrom MR, et al. Percutaneous cryoablation of renal masses >/=3 cm: efficacy and safety in treatment of 108 patients. J Endourol. 2010;24:1255–62.

    Article  PubMed  Google Scholar 

  32. Campbell SC, Krishnamurthi V, Chow G, Hale J, Myles J, Novick AC. Renal cryosurgery: experimental evaluation of treatment parameters. Urology. 1998;52(1):29–33.

    Article  PubMed  CAS  Google Scholar 

  33. Atwell TD, Farrell MA, Callstrom MR, et al. Percutaneous cryoablation of 40 solid renal tumors with US guidance and CT monitoring: initial experience. Radiology. 2007;243(1):276–83.

    Article  PubMed  Google Scholar 

  34. Vricella GJ, Haaga JR, Adler BL, et al. Percutaneous cryoablation of renal masses: impact of patient selection and treatment parameters on outcomes. Urology. 2011;77(3):649–54.

    Article  PubMed  Google Scholar 

  35. Matin SF, Ahrar K, Cadeddu JA, et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol. 2006;176(5):1973–7.

    Article  PubMed  Google Scholar 

  36. Raman JD, Stern JM, Zeltser I, Kabbani W, Cadeddu JA. Absence of viable renal carcinoma in biopsies performed more than 1 year following radio frequency ablation confirms reliability of axial imaging. J Urol. 2008;179(6):2142–5.

    Article  PubMed  Google Scholar 

  37. Matsumoto ED, Watumull L, Johnson DB, et al. The radiographic evolution of radio frequency ablated renal tumors. J Urol. 2004;172(1):45–8.

    Article  PubMed  Google Scholar 

  38. Karam JA, Ahrar K, Jonasch E, et al. Radiofrequency ablation (RFA) of renal tumors: clinical, radiographic, and pathologic results from a Tertiary Cancer Center. In: Genitourinary cancers symposium, San Francisco; 2010.

    Google Scholar 

  39. Lokken RP, Gervais DA, Arellano RS, et al. Inflammatory nodules mimic applicator track seeding after percutaneous ablation of renal tumors. Am J Roentgenol. 2007;189(4):845–8.

    Article  Google Scholar 

  40. Javadi S, Matin SF, Tamboli P, Ahrar K. Unexpected atypical findings on CT after radiofrequency ablation for small renal-cell carcinoma and the role of percutaneous biopsy. J Vasc Interv Radiol. 2007;18:1186–91.

    Article  PubMed  Google Scholar 

  41. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol. 2008;179(1):75–9 [discussion 79–80].

    Article  PubMed  Google Scholar 

  42. Raman JD, Raj GV, Lucas SM, et al. Renal functional outcomes for tumours in a solitary kidney managed by ablative or extirpative techniques. BJU Int. 2010;105(4):496–500.

    Article  PubMed  Google Scholar 

  43. Weisbrod AJ, Atwell TD, Frank I, et al. Percutaneous cryoablation of masses in a solitary kidney. Am J Roentgenol. 2010;194(6):1620–5.

    Article  Google Scholar 

  44. Hoffmann RT, Jakobs TF, Kubisch CH, et al. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results. Eur J Radiol. 2010;73(3):652–6.

    Article  PubMed  Google Scholar 

  45. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol. 2006;175(2):425–31.

    Article  PubMed  Google Scholar 

  46. Bhayani SB, Allaf ME, Su LM, Solomon SB. Neuromuscular complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;65(3):592.

    Article  PubMed  Google Scholar 

  47. Weizer AZ, Raj GV, O’Connell M, Robertson CN, Nelson RC, Polascik TJ. Complications after percutaneous radiofrequency ablation of renal tumors. Urology. 2005;66(6):1176–80.

    Article  PubMed  Google Scholar 

  48. Johnson DB, Solomon SB, Su LM, et al. Defining the complications of cryoablation and radio frequency ablation of small renal tumors: a multi-institutional review. J Urol. 2004;172(3):874–7.

    Article  PubMed  Google Scholar 

  49. Liu NW, Khurana K, Sudarshan S, Pinto PA, Linehan WM, Bratslavsky G. Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes. J Urol. 2010;183(5):1719–24.

    Article  PubMed  Google Scholar 

  50. Bratslavsky G, Liu JJ, Johnson AD, et al. Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol. 2008;179(1):67–70.

    Article  PubMed  Google Scholar 

  51. Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E. Patterns of intervention for renal lesions in von Hippel–Lindau disease. BJU Int. 2008;102(8):940–5.

    Article  PubMed  Google Scholar 

  52. Pautler SE, Pavlovich CP, Mikityansky I, et al. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors. Can J Urol. 2001;8(4):1330–3.

    PubMed  CAS  Google Scholar 

  53. Shingleton WB, Sewell Jr PE. Percutaneous renal cryoablation of renal tumors in patients with von Hippel–Lindau disease. J Urol. 2002;167(3):1268–70.

    Article  PubMed  Google Scholar 

  54. Nguyen CT, Lane BR, Kaouk JH, et al. Surgical salvage of renal cell carcinoma recurrence after thermal ablative therapy. J Urol. 2008;180(1):104–9 [discussion 9].

    Article  PubMed  Google Scholar 

  55. Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G. Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience. J Urol. 2009;182(5):2158–63.

    Article  PubMed  Google Scholar 

  56. Dick EA, Wragg P, Joarder R, et al. Feasibility of abdomino-pelvic T1-weighted real-time thermal mapping of laser ablation. J Magn Reson Imaging. 2003;17(2):197–205.

    Article  PubMed  Google Scholar 

  57. Gettman MT, Lotan Y, Lindberg G, et al. Laparoscopic interstitial laser coagulation of renal tissue with and without hilar occlusion in the porcine model. J Endourol. 2002;16(8):565–70.

    Article  PubMed  Google Scholar 

  58. Matin SF, Tinkey PT, Borne AT, Stephens LC, Sherz A, Swanson DA. A pilot trial of vascular targeted photodynamic therapy for renal tissue. J Urol. 2008;180(1):338–42.

    Article  PubMed  CAS  Google Scholar 

  59. Murota T, Kawakita M, Oguchi N, et al. Retroperitoneoscopic partial nephrectomy using microwave coagulation for small renal tumors. Eur Urol. 2002;41(5):540–5.

    Article  PubMed  Google Scholar 

  60. Terai A, Ito N, Yoshimura K, et al. Laparoscopic partial nephrectomy using microwave tissue coagulator for small renal tumors: usefulness and complications. Eur Urol. 2004;45(6):744–8.

    Article  PubMed  Google Scholar 

  61. Illing RO, Kennedy JE, Wu F, et al. The safety and feasibility of extracorporeal high-intensity focused ultrasound (HIFU) for the treatment of liver and kidney tumours in a Western population. Br J Cancer. 2005;93(8):890–5.

    Article  PubMed  CAS  Google Scholar 

  62. Hacker A, Michel MS, Marlinghaus E, Kohrmann KU, Alken P. Extracorporeally induced ablation of renal tissue by high-intensity focused ultrasound. BJU Int. 2006;97(4):779–85.

    Article  PubMed  Google Scholar 

  63. Ponsky LE, Crownover RL, Rosen MJ, et al. Initial evaluation of Cyberknife technology for extracorporeal renal tissue ablation. Urology. 2003;61(3):498–501.

    Article  PubMed  Google Scholar 

  64. Lieberthal W. Biology of ischemic and toxic renal tubular cell injury: role of nitric oxide and the inflammatory response. Curr Opin Nephrol Hypertens. 1998;7:289–95.

    Article  PubMed  CAS  Google Scholar 

  65. Sidana A, Chowdhury WH, Fuchs EJ, Rodriguez R. Cryoimmunotherapy in urologic oncology. Urology. 2010;75(5):1009–14.

    Article  PubMed  Google Scholar 

  66. Staren ED, Sabel MS, Gianakakis LM, et al. Cryosurgery of breast cancer. Arch Surg. 1997;132(1):28–33.

    Article  PubMed  CAS  Google Scholar 

  67. Matin SF, Sharma P, Gill IS, et al. Immunological response to renal cryoablation in an in vivo orthotopic renal cell carcinoma murine model. J Urol. 2010;183(1):333–8.

    Article  PubMed  Google Scholar 

  68. Sanchez-Ortiz RF, Tannir N, Ahrar K, Wood CG. Spontaneous regression of pulmonary metastases from renal cell carcinoma after radio frequency ablation of primary tumor: an in situ tumor vaccine? J Urol. 2003;170(1):178–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Minimally Invasive New Technology in Oncologic Surgery (MINTOS), The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1373, Houston, TX, 77030, USA

    Surena F. Matin MD, FACS

  2. Department of Diagnostic Radiology, Section of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Kamran Ahrar MD

Authors
  1. Surena F. Matin MD, FACS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kamran Ahrar MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Surena F. Matin MD, FACS .

Editor information

Editors and Affiliations

  1. Glickman Urological and Kidney Institute, Center for Urologic Oncology, Cleveland Clinic, Cleveland, 44195, Ohio, USA

    Steven C. Campbell

  2. College of Medicine, Case Western Reserve University, Cleveland Clinic Lerner, Department of Solid Tumor Oncology, Cleveland, 44195, Ohio, USA

    Brian I. Rini

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Matin, S.F., Ahrar, K. (2013). Thermal Ablation. In: Campbell, S., Rini, B. (eds) Renal Cell Carcinoma. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-062-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-62703-062-5_9

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-62703-061-8

  • Online ISBN: 978-1-62703-062-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation